10 likes | 105 Views
Day 1: May 12, 2010 Venue: UPR Medical Sciences Campus 0800 Welcome - President of the UPR/Medical School Chancellor 0810 Welcome – Murray Lumpkin, Deputy Commissioner for International Programs, U.S. Food and Drug Administration 0820 Keynote , TBD 0900 Session 1
E N D
Day 1: May 12, 2010 Venue: UPR Medical Sciences Campus 0800 Welcome - President of the UPR/Medical School Chancellor 0810 Welcome – Murray Lumpkin, Deputy Commissioner for International Programs, U.S. Food and Drug Administration 0820 Keynote, TBD 0900 Session 1 SUCCESSES AND CHALLENGES IN PHARMACOGENOMICS Chair: Larry Lesko P1: Larry Lesko 0930 P2: George Patrinos P3: Howard McLeod 1030 COFFEE BREAK P4: Federico Innocenti P5: Luis Parodi 1200 P6: Felix Frueh 1230 LUNCH 1330 Session 2 POPULATION GENOMICS STUDIES Chair: Gualberto Ruaño P7: Jorge Duconge (Puerto Rico) 1400 P8: TBD (México) 1430 P9: Luis Linares (Colombia) 1500 P10: Guilherme Suarez-Kurtz (Brazil) P11: Esteban Parra (South America) END OF DAY 1 Reception Cocktail Executive Director of PRIDCO 1930 Dinner 1st Latin American Pharmacogenomics Congress 1st Latin American Pharmacogenomics Congress 1st Latin American Pharmacogenomics Congress Day 2: May 13, 2010 Venue: FDA Campus 0900 Welcome – Maridalia Torres, Puerto Rico District Director, FDA 0915 Session 3 REGULATORY ISSUES IN PHARMACOGENOMICS Chair: Issam Zineh P12: Michael Pacanowski (FDA) 0945 P13: Marisa Papaluca (EMA) 1015 P14: Dirceu Greco (Brazil) 1045 COFFEE BREAK • Session 4INFRASTRUCTURE FOR DEVELOPMENT OF PHARMACOGENOMICS Chair: Federico Goodsaid P15: Federico Goodsaid 1130 P16: Rick Hockett 1200 P17: Kimberly Popovitz • P18: Gualberto Ruaño 1300 LUNCH • Session 5 CASE STUDIES IN LATIN AMERICAN PHARMACOGENOMICS Chair: Guilherme Suarez-Kurtz P19: Gerardo Jiménez (México) • P20: Mara Helena Hutz (Brazil) • P21: Diadelis Remírez (Cuba) • P22: Esteban Burchard (US) • P23: Adrián Llerena (Spain) • END OF DAY 2 1900 Reception Cocktail 1930 Dinner Day 3: May 14, 2010 Venue: AMGEN Campus 0900 Welcome – Emilio Rivera, VP of Amgen Operations in Puerto Rico 0915 Session 6 PHARMACOGENOMIC BIOMARKERS IN THE PHARMACEUTICAL INDUSTRY Chair: Scott Patterson P24: Scott Patterson 0945 P25: TBD1 1015 P26: TBD2 1045 COFFEE BREAK • Session 7PAYING FOR PHARMACOGENOMICS Chair: Felix Frueh P27: TBD3 1130 P28: TBD4 1200 P29: TBD5 • P30: TBD6 • LUNCH AND MEETING SUMMARY 1400 AMGEN Tour